Literature DB >> 21999975

Associations of mood and anxiety disorders with obesity: comparisons by ethnicity.

Jamie S Bodenlos1, Stephenie C Lemon, Kristin L Schneider, Madeline A August, Sherry L Pagoto.   

Abstract

OBJECTIVE: The aim of this study is to compare the associations of mood and anxiety disorders (12 months and past diagnosis) with obesity among ethnically diverse adults.
METHODS: Data from Caucasians, African American, and Latinos in the National Comorbidity Survey Replication (NCS-R), National Latino and Asian American Study (NLAAS), and National Study of American Life (NSAL) were analyzed (n=17,445). Multivariate logistic regression models tested the associations between 12 month and past diagnosis of mood and anxiety disorders with obesity (body mass index ≥ 30kg/m²).
RESULTS: Approximately 52% of the sample was female and 24% obese. Among Caucasians, 12-month mood disorder (OR=1.30, 95% CI=1.05, 1.62), past diagnosis of mood disorder (OR=1.37, 95% CI=1.11, 1.69) and 12-month anxiety disorder (OR=1.40, 95% CI=1.02, 1.68) were associated with greater likelihood of obesity. Among African Americans, past year anxiety disorder (OR=1.63, 95% CI=0.92, 1.67) was associated with greater likelihood of obesity, and a trend toward an association between 12 month mood disorder (OR=1.24, 95% CI=0.92, 1.67) and obesity was observed. Similarly among Latinos, past year anxiety disorder (OR=1.45, 95% CI=1.00, 1.99) was associated with greater likelihood of obesity, and a trend toward an association between 12-month mood disorder (OR=1.26, 95% CI=0.94, 2.01) was observed. Tests of statistical interaction to assess heterogeneity of the associations of mood and anxiety disorders with obesity, comparing African Americans and Latinos to Caucasians, suggest differences in the association of past diagnosis of mood disorder with obesity (P<.10 for both groups).
CONCLUSIONS: Results suggest similar associations between 12-month mood and anxiety disorders with obesity across groups. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21999975     DOI: 10.1016/j.jpsychores.2011.03.004

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  7 in total

1.  Do genetic risk scores for body mass index predict risk of phobic anxiety? Evidence for a shared genetic risk factor.

Authors:  S Walter; M M Glymour; K Koenen; L Liang; E J Tchetgen Tchetgen; M Cornelis; S-C Chang; M Rewak; E Rimm; I Kawachi; L D Kubzansky
Journal:  Psychol Med       Date:  2014-05-28       Impact factor: 7.723

Review 2.  Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease.

Authors:  Karen E Stewart; James L Levenson
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

3.  Race-specific associations between psychological distress and obesity: the role of social cohesion.

Authors:  Nicole D Fields; Brian W Whitcomb; Elizabeth R Bertone-Johnson; Airín D Martínez; Nicole A VanKim
Journal:  Ethn Health       Date:  2022-03-15       Impact factor: 2.732

4.  Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.

Authors:  Karen E Stewart; Deborah L Haller; Carol Sargeant; James L Levenson; Puneet Puri; Arun J Sanyal
Journal:  Liver Int       Date:  2014-03-10       Impact factor: 5.828

Review 5.  Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review.

Authors:  Ke Ma; Hongxiu Zhang; Zulqarnain Baloch
Journal:  Int J Mol Sci       Date:  2016-05-14       Impact factor: 5.923

6.  Searching for the causal effects of body mass index in over 300 000 participants in UK Biobank, using Mendelian randomization.

Authors:  Louise A C Millard; Neil M Davies; Kate Tilling; Tom R Gaunt; George Davey Smith
Journal:  PLoS Genet       Date:  2019-02-01       Impact factor: 5.917

7.  Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression.

Authors:  Christian Labenz; Yvonne Huber; Maurice Michel; Michael Nagel; Peter R Galle; Karel Kostev; Jörn M Schattenberg
Journal:  Hepatol Commun       Date:  2020-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.